Study on the safety and feasibility of the treatment of chronic dacryocystitis with novel functional nasolacrimal duct decompression

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030821

Enrollment

Unknown

Registered

2020-03-15

Start date

2020-04-30

Completion date

Unknown

Last updated

2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Dacryocystitis

Interventions

1:novel functional nasolacrimal duct decompression

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Twenty-two patients with chronic dacryocystitis at our ENT hospital were inclusion.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Anatomy of nasolacrimal duct;Lacrimal passage occlusion;Balloon catheter dilates membranous nasolacrimal duct;	—

Countries

China

Contacts

Public ContactZhixian Liu

Otorhinolaryngology Hospital of Longgang District of Shenzhen

zhixianl@126.com+86 15999656079

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026